Børset M - Search Results

1

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease.

Seidel C, Hjertner Ø, Abildgaard N, Heickendorff L, Hjorth M, Westin J, Nielsen JL, Hjorth-Hansen H, Waage A, Sundan A, Børset M; Nordic Myeloma Study Group. Seidel C, et al. Among authors: borset m. Blood. 2001 Oct 1;98(7):2269-71. doi: 10.1182/blood.v98.7.2269. Blood. 2001. PMID: 11568016 Free article.

2

Interleukin-21 is a growth and survival factor for human myeloma cells.

Brenne AT, Ro TB, Waage A, Sundan A, Borset M, Hjorth-Hansen H. Brenne AT, et al. Among authors: borset m. Blood. 2002 May 15;99(10):3756-62. doi: 10.1182/blood.v99.10.3756. Blood. 2002. PMID: 11986233 Free article.

3

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells.

Standal T, Seidel C, Hjertner Ø, Plesner T, Sanderson RD, Waage A, Borset M, Sundan A. Standal T, et al. Among authors: borset m. Blood. 2002 Oct 15;100(8):3002-7. doi: 10.1182/blood-2002-04-1190. Blood. 2002. PMID: 12351414 Free article.

4

Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor.

Standal T, Borset M, Lenhoff S, Wisloff F, Stordal B, Sundan A, Waage A, Seidel C. Standal T, et al. Among authors: borset m. Blood. 2002 Dec 1;100(12):3925-9. doi: 10.1182/blood-2002-05-1406. Epub 2002 Jul 18. Blood. 2002. PMID: 12393395 Free article.

5

HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.

Standal T, Abildgaard N, Fagerli UM, Stordal B, Hjertner O, Borset M, Sundan A. Standal T, et al. Among authors: borset m. Blood. 2007 Apr 1;109(7):3024-30. doi: 10.1182/blood-2006-07-034884. Blood. 2007. PMID: 17138824 Free article.

6

Bone disease in multiple myeloma.

Hjertner Ø, Standal T, Børset M, Sundan A, Waage A. Hjertner Ø, et al. Among authors: borset m. Med Oncol. 2006;23(4):431-41. doi: 10.1385/mo:23:4:431. Med Oncol. 2006. PMID: 17303901 Review.

7

Why do myeloma patients have bone disease? A historical perspective.

Børset M, Sundan A, Waage A, Standal T. Børset M, et al. Blood Rev. 2020 May;41:100646. doi: 10.1016/j.blre.2019.100646. Epub 2019 Nov 29. Blood Rev. 2020. PMID: 31810754 Free article. Review.

8

Hepatocyte growth factor and its receptor c-met in multiple myeloma.

Börset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A. Börset M, et al. Blood. 1996 Nov 15;88(10):3998-4004. Blood. 1996. PMID: 8916966 Free article.

9

Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group.

Seidel C, Børset M, Turesson I, Abildgaard N, Sundan A, Waage A. Seidel C, et al. Among authors: borset m. Blood. 1998 Feb 1;91(3):806-12. Blood. 1998. PMID: 9446640 Free article.

10

Role of hepatocyte growth factor and its receptor c-met in multiple myeloma.

Seidel C, Børset M, Hjorth-Hansen H, Sundan A, Waage A. Seidel C, et al. Among authors: borset m. Med Oncol. 1998 Sep;15(3):145-53. doi: 10.1007/BF02821933. Med Oncol. 1998. PMID: 9819791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99 results

Search Page

Filters